Peregrine Pharmaceuticals Names Leading Influenza Expert to Its Scientific Resource Board

Peregrine Pharmaceuticals Announces $6.7 Million Equity Financing

Peregrine's Manufacturing Subsidiary Announces Bioproduction Contract With Major Leading Cancer Center

Peregrine Pharmaceuticals Names Leading Viral Experts to Its Scientific Resource Board

Peregrine Pharmaceuticals Announces Defense Department Grant to Study Tarvacin(TM) Platform for Prostate Cancer

Peregrine Pharmaceuticals to Present at Rodman & Renshaw Annual Healthcare Conference

Peregrine Pharmaceuticals Evaluating Therapeutic Opportunities for Tarvacin(TM) Against Influenza Viruses Including Avian Flu

Peregrine Pharmaceuticals Announces Additional Tarvacin(TM) Clinical Trial Site at M.D. Anderson Cancer Center

Peregrine Pharmaceuticals to Webcast Annual Meeting of Stockholders

Peregrine Pharmaceuticals' Avid Bioservices Awarded Contract to Produce Clinical Phase Antibody